Market Cap | 1.38B | P/E | - | EPS this Y | -39.10% | Ern Qtrly Grth | - |
Income | -260.73M | Forward P/E | -10.26 | EPS next Y | 37.50% | 50D Avg Chg | 39.00% |
Sales | 101.78M | PEG | 1.28 | EPS past 5Y | - | 200D Avg Chg | 9.00% |
Dividend | N/A | Price/Book | 7.59 | EPS next 5Y | -9.00% | 52W High Chg | -30.00% |
Recommedations | 2.00 | Quick Ratio | 6.15 | Shares Outstanding | 61.13M | 52W Low Chg | 57.00% |
Insider Own | 0.57% | ROA | -47.99% | Shares Float | 44.84M | Beta | 2.07 |
Inst Own | 125.00% | ROE | -143.42% | Shares Shorted/Prior | 9.34M/9.88M | Price | 24.32 |
Gross Margin | 88.80% | Profit Margin | -254.89% | Avg. Volume | 772,256 | Target Price | 59.30 |
Oper. Margin | -139.21% | Earnings Date | Nov 5 | Volume | 3,218,385 | Change | 6.90% |
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
HC Wainwright & Co. | Buy | Sep 18, 24 |
JMP Securities | Market Outperform | Sep 17, 24 |
Needham | Buy | Aug 7, 24 |
Needham | Buy | Jul 25, 24 |
Canaccord Genuity | Buy | May 8, 24 |
B of A Securities | Neutral | May 8, 24 |
Needham | Buy | May 7, 24 |
Needham | Buy | Apr 26, 24 |
Wells Fargo | Overweight | Apr 18, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Feb 01 | Sell | 45.06 | 1,492 | 67,230 | 3,021 | 02/05/24 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Feb 01 | Sell | 45.06 | 1,616 | 72,817 | 75,215 | 02/05/24 |
Shulman Joseph | Chief Technical Offi.. Chief Technical Officer | Feb 01 | Sell | 45.06 | 1,324 | 59,659 | 2,614 | 02/05/24 |
Meeker David P | President and CEO President and CEO | Feb 01 | Sell | 45.06 | 4,361 | 196,507 | 121,099 | 02/05/24 |
Cramer Pamela J. | Chief Human Resource.. Chief Human Resources Officer | Feb 01 | Sell | 45.06 | 946 | 42,627 | 10,122 | 02/05/24 |
Shulman Joseph | Chief Technical Offi.. Chief Technical Officer | Dec 27 | Sell | 50.01 | 12,941 | 647,179 | 12/29/23 | |
Shulman Joseph | Chief Technical Offi.. Chief Technical Officer | Dec 27 | Option | 21.38 | 9,200 | 196,696 | 7,926 | 12/29/23 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Nov 24 | Sell | 35.02 | 10,974 | 384,309 | 61,406 | 11/28/23 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Nov 24 | Option | 6.88 | 10,974 | 75,501 | 72,380 | 11/28/23 |
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Nov 08 | Sell | 28.33 | 9,150 | 259,219 | 1,647 | 11/13/23 |
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Nov 08 | Option | 6.8 | 9,150 | 62,220 | 5,085 | 11/13/23 |
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Nov 03 | Sell | 28 | 80 | 2,240 | 1,647 | 11/07/23 |
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Nov 03 | Option | 6.8 | 80 | 544 | 1,727 | 11/07/23 |
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Sep 05 | Sell | 28.05 | 6,166 | 172,956 | 1,647 | 09/07/23 |
Lee Jennifer Kayden | EVP, Head of North A.. EVP, Head of North America | Sep 05 | Option | 6.8 | 4,519 | 30,729 | 7,813 | 09/07/23 |
Cramer Pamela J. | Chief Human Resource.. Chief Human Resources Officer | Jul 26 | Sell | 17.64 | 930 | 16,405 | 8,418 | 07/28/23 |
Roberts William T. | Chief Accounting Off.. Chief Accounting Officer | Mar 29 | Sell | 17.5 | 912 | 15,960 | 7,872 | 03/31/23 |
Shulman Joseph | Chief Technical Offi.. Chief Technical Officer | Feb 11 | Sell | 26.87 | 554 | 14,886 | 3,741 | 02/14/23 |
Chien Jennifer | EVP, Head of North A.. EVP, Head of North America | Feb 11 | Sell | 26.87 | 635 | 17,062 | 4,940 | 02/14/23 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Feb 11 | Sell | 26.87 | 702 | 18,863 | 59,406 | 02/14/23 |
Cramer Pamela J. | Chief Human Resource.. Chief Human Resources Officer | Feb 09 | Sell | 27.51 | 843 | 23,191 | 6,142 | 02/14/23 |
Mazabraud Yann | EVP, Head of Interna.. EVP, Head of International | Feb 09 | Sell | 27.51 | 1,563 | 42,998 | 2,973 | 02/14/23 |
Roberts William T. | Chief Accounting Off.. Chief Accounting Officer | Feb 09 | Sell | 27.51 | 969 | 26,657 | 6,284 | 02/14/23 |
Shulman Joseph | Chief Technical Offi.. Chief Technical Officer | Feb 09 | Sell | 27.51 | 931 | 25,612 | 2,732 | 02/14/23 |
Chien Jennifer | EVP, Head of North A.. EVP, Head of North America | Feb 09 | Sell | 27.51 | 1,204 | 33,122 | 3,544 | 02/14/23 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Feb 09 | Sell | 27.51 | 1,413 | 38,872 | 57,764 | 02/14/23 |
Cramer Pamela J. | Chief Human Resource.. Chief Human Resources Officer | Jul 26 | Sell | 11.68 | 901 | 10,524 | 2,224 | 07/28/22 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Jun 30 | Sell | 4.08 | 7,547 | 30,792 | 57,614 | 07/06/22 |
Roberts William T. | Chief Accounting Off.. Chief Accounting Officer | Mar 29 | Sell | 11.13 | 1,023 | 11,386 | 1,477 | 03/31/22 |
Shulman Joseph | Chief Technical Offi.. Chief Technical Officer | Feb 11 | Sell | 6.1 | 557 | 3,398 | 1,006 | 02/15/22 |
Smith Hunter C | Chief Financial Offi.. Chief Financial Officer | Feb 11 | Sell | 6.1 | 833 | 5,081 | 40,161 | 02/15/22 |
Mazabraud Yann | EVP, Head of Interna.. EVP, Head of International | Feb 11 | Sell | 6.1 | 934 | 5,697 | 1,098 | 02/15/22 |
Chien Jennifer | EVP, Head of North A.. EVP, Head of North America | Feb 11 | Sell | 6.1 | 722 | 4,404 | 1,310 | 02/15/22 |